Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina

International Journal of Infectious Diseases

Volumn 6, Issue 1, 2002, Pages 9-16

  Fallo, Aurelia A ^a   Dobrzanski Nisiewicz, Wanda ^a   Sordelli, Nora ^a   Alejandra Cattaneo, María ^a   Scott, Gwendolyn ^b   López, Eduardo L ^a,c  

^a Division of Pediatric Infectious Disease Hospital de Nios Dr Ricardo Gutiérrez   (Argentina)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARGENTINA; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; SEROCONVERSION; SEXUAL TRANSMISSION; SURVIVAL RATE; VERTICAL TRANSMISSION;

EID: 0036290934     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(02)90129-3     Document Type: Article

References (44)

1. Advanced report of final mortality statistics, 1992
2. Children born to women with HIV-1 infection: Natural history and risk of transmission
3. Perinatally acquired human immunodeficiency virus infection
4. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age
5. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
6. 1995 Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus
7. Mother-to-child transmission of the human immunodeficiency virus
8. Risk factors for mother-to-child transmission of HIV-1
9. Mother-to-child transmission of human immunodeficiency type 1: Risk of infection and correlates of transmission
10. Current insights regarding vertical transmission
11. 1991-AIDS-United States
12. Pediatric human immunodeficiency virus infection
13. Vertically acquired HIV infection in the United States
14. Sexual contacts of intravenous drug abusers: Implications for the next spread of the AIDS epidemic
15. AIDS surveillance in Europe
16. AIDS: An international perspective
17. Heterosexual transmission of HIV
18. State of the art mini lecture. HIV clinical trials: An overview
19. Analysis of maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus types 1
20. Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus type 1 from mother to infant
21. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1
22. Medical management of newborns and infants born to human immunodeficiency virus-seropositive mothers
23. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection
24. Clinical aspects of HIV infection in developing countries
25. Special considerations for developing nations
26. Clinical features of pediatric AIDS in Uganda
27. Bacterial infections in HIV-infected children in Argentina
28. Bacterial infections in human immunodeficiency virus-infected children
29. Sepsis in children with human immunodeficiency virus infection
30. Pneumocystis carinii pneumonia: An uncommon cause of death in African patients with acquired immunodeficiency syndrome
31. Pneumocystis carinii pneumonia
32. Prognosis of human immunodeficiency virus infection in children and adolescents
33. Incubation periods for paediatric AIDS patients
34. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for bimodal expression of clinical and biologic symptoms
35. Pediatric spectrum of disease project. Survival of children with perinatal HIV infection: Evidence of two distinct populations
36. A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors
37. Features of children perinatally infected with HIV-1 surviving longer than 5 years
38. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection
39. Prognostic factors and survival in children with perinatal HIV-1 infection